Clinical Trial Update: Patient Interview Study to Explore the Impact of Gene Therapy in Hemophilia A & B

View source ↗

Summary

Pfizer-sponsored clinical trial assessing gene therapy for Hemophilia A and Hemophilia B has been withdrawn from clinicalTrials.gov.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• Pfizer investigational gene therapy (unspecified)

Snippet

Sponsor: Pfizer | Conditions: Hemophilia A, Hemophilia B | Status: WITHDRAWN